Medicina ClinicaPub Date : 2025-07-16DOI: 10.1016/j.medcli.2025.107038
Beatriz Sánchez-Álamo
{"title":"Estrategias terapéuticas en las vasculitis asociadas a anticuerpos anticitoplasma de neutrófilo","authors":"Beatriz Sánchez-Álamo","doi":"10.1016/j.medcli.2025.107038","DOIUrl":"10.1016/j.medcli.2025.107038","url":null,"abstract":"","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"165 3","pages":"Article 107038"},"PeriodicalIF":2.6,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144633314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medicina ClinicaPub Date : 2025-07-14DOI: 10.1016/j.medcli.2025.107067
José María Medina-Gil , Acerina Rodríguez-Reyes , Efrén Martínez-Quintana
{"title":"Impact of vericiguat on functional class and hospitalizations in patients with heart failure and reduced ejection fraction: A retrospective cohort study","authors":"José María Medina-Gil , Acerina Rodríguez-Reyes , Efrén Martínez-Quintana","doi":"10.1016/j.medcli.2025.107067","DOIUrl":"10.1016/j.medcli.2025.107067","url":null,"abstract":"","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"165 5","pages":"Article 107067"},"PeriodicalIF":2.6,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144623386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medicina ClinicaPub Date : 2025-07-02DOI: 10.1016/j.medcli.2025.107041
Maria D. Ballesteros-Pomar , Irene Bretón
{"title":"Efectos adversos y otros aspectos de los fármacos con efecto incretínico","authors":"Maria D. Ballesteros-Pomar , Irene Bretón","doi":"10.1016/j.medcli.2025.107041","DOIUrl":"10.1016/j.medcli.2025.107041","url":null,"abstract":"<div><div>The most frequent adverse effects related to arGLP-1 are gastrointestinal manifestations, which are usually mild to moderate and diminish after a few days or weeks of continued treatment. Although warnings about the risk of pancreatitis, pancreatic cancer or thyroid cancer continue to be maintained in the data sheets, numerous studies and meta-analyses do not indicate a causal relationship. The relationship with suicidality has not been confirmed either, but they should be prescribed with caution in patients with a history of depression or suicide attempts. The risk of bronchoaspiration should be considered in the perioperative period or with the performance of endoscopic procedures. The effect on body composition is generally favorable, but there is a risk of sarcopenia, which should be prevented. On the other hand, possible benefits are being described for its use in other clinical conditions, such as neurodegenerative diseases or addictions.</div></div>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"165 2","pages":"Article 107041"},"PeriodicalIF":2.6,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144523442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medicina ClinicaPub Date : 2025-06-25DOI: 10.1016/j.medcli.2025.107061
Zhibo Zhou , Shan Xiao , Xiaoyuan Guo , Yiling He , Shi Chen , Hongbo Yang , Hui Pan , Huijuan Zhu
{"title":"Metabolic profiles of Turner syndrome: A real-world cohort study","authors":"Zhibo Zhou , Shan Xiao , Xiaoyuan Guo , Yiling He , Shi Chen , Hongbo Yang , Hui Pan , Huijuan Zhu","doi":"10.1016/j.medcli.2025.107061","DOIUrl":"10.1016/j.medcli.2025.107061","url":null,"abstract":"<div><h3>Background and objective</h3><div>Turner syndrome (TS), primarily characterized by premature ovarian insufficiency, is a disease resulting from a complete or partial absence of the second X chromosome. This study aims to describe the prevalence of metabolic comorbidities in TS patients of different ages and karyotypes.</div></div><div><h3>Methods</h3><div>The medical history, diagnosis, physical examination, laboratory examination and imaging examination data of 145 TS patients were obtained from the medical files.</div></div><div><h3>Results</h3><div>(1) In total, 4.1% of the TS patients in this cohort were diagnosed with hypertension, and elderly patients had higher blood pressure. (2) 6.9% of patients were diagnosed with diabetes, and monosomic TS had a lower TyG index. (3) The prevalence of dyslipidemia and fatty liver was 20.0% and 16.7% respectively. TS patients treated with recombinant human growth hormone (rhGH) had significantly higher LDL-C and Apo-A1 levels. (4) The prevalence of hyperuricemia was 27.6%, and higher uric acid levels were observed in young patients and those receiving rhGH treatment. A total of 17.2% of patients were diagnosed with liver dysfunction. (5) The prevalence of low bone mass, which was higher in elderly patients and those without rhGH treatment, was 53.8% in TS patients older than 19 years.</div></div><div><h3>Conclusions</h3><div>TS patients have a higher prevalence of metabolic comorbidities, including dyslipidemia, fatty liver, hyperuricemia, liver dysfunction and low bone mass. RhGH treatment in childhood had some positive effects on glucose, lipid and bone metabolism in young adulthood. Therefore, additional attention should be given to metabolic comorbidities in TS patients at high risk.</div></div>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"165 4","pages":"Article 107061"},"PeriodicalIF":2.6,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144472192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medicina ClinicaPub Date : 2025-06-25DOI: 10.1016/j.medcli.2025.107049
Rita González-Resina , Robert R. Rodríguez-Carpio , Ana C. Godoy-Molias
{"title":"Diagnosis of relapsed multiple myeloma presenting as testicular plasmacytoma with stable bone marrow disease","authors":"Rita González-Resina , Robert R. Rodríguez-Carpio , Ana C. Godoy-Molias","doi":"10.1016/j.medcli.2025.107049","DOIUrl":"10.1016/j.medcli.2025.107049","url":null,"abstract":"","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"165 3","pages":"Article 107049"},"PeriodicalIF":2.6,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144471324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medicina ClinicaPub Date : 2025-06-25DOI: 10.1016/j.medcli.2025.107076
Enrique Casado , Guillermo Martínez-Díaz-Guerra , José Ramon Caeiro
{"title":"Los análogos de la PTH/PTHrP como tratamiento osteoanabólico de los pacientes con osteoporosis","authors":"Enrique Casado , Guillermo Martínez-Díaz-Guerra , José Ramon Caeiro","doi":"10.1016/j.medcli.2025.107076","DOIUrl":"10.1016/j.medcli.2025.107076","url":null,"abstract":"<div><div>Teriparatide (TPTD) and abaloparatide (ABL) are osteoanabolic drugs belonging to the group of parathyroid hormone analogues and parathyroid hormone-related protein analogues, respectively. Both drugs have been shown to be effective and safe in the treatment of postmenopausal osteoporosis (PMO), reducing the risk of vertebral and nonvertebral fractures and improving bone microarchitecture, especially in patients with severe osteoporosis. For this reason, guidelines recommend their use as first-line treatment for patients at very high risk of fracture. Although TPTD and ABL act on the same receptor, PTHR1, they trigger a different signaling response, which explains why their effects on bone remodeling are also different, with similar osteoanabolic action, but with less stimulation of resorption by ABL, which confers a greater benefit on cortical bone.</div></div>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"165 4","pages":"Article 107076"},"PeriodicalIF":2.6,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144472194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medicina ClinicaPub Date : 2025-06-25DOI: 10.1016/j.medcli.2025.107062
Silvana Alejandra Nuñez , Pehuén Fernández , Walter Douthat , Javier de Arteaga , Emanuel José Saad , Jorge de la Fuente , Carlos Chiurchiu
{"title":"Donación renal: criterios de aceptación y su influencia a los 5 y 10 años post donación","authors":"Silvana Alejandra Nuñez , Pehuén Fernández , Walter Douthat , Javier de Arteaga , Emanuel José Saad , Jorge de la Fuente , Carlos Chiurchiu","doi":"10.1016/j.medcli.2025.107062","DOIUrl":"10.1016/j.medcli.2025.107062","url":null,"abstract":"<div><h3>Introduction</h3><div>Acceptance criteria for kidney donors (KDs) have become more flexible over time, raising questions about their long-term consequences. The objective of this study was to evaluate changes in the baseline characteristics of accepted KDs and to analyze their evolution after donation.</div></div><div><h3>Methods</h3><div>A cohort study was conducted that included all KDs from our institution from 2010 to 2017. Baseline characteristics were compared by period and follow-up was carried out up to 10<!--> <!-->years after donation.</div></div><div><h3>Results</h3><div>169 KDs aged 45.6<!--> <!-->±<!--> <!-->12.2<!--> <!-->years were included, mostly women (63.9%). The main comorbidity they presented was obesity (29.6%) and controlled arterial hypertension (10.7%). KDs showed significant differences in estimated glomerular filtration rate (eGFR) with lower values in the last study period (<em>P</em> <!-->=<!--> <!-->.002). Progression to chronic kidney disease (CKD)<!--> <!-->III-a was 31% (95%<!--> <!-->CI: 23.5-39.6) and III-b 3.9% (95%<!--> <!-->CI: 0.5-7.2). Related risk factors were age (HRa<!--> <!-->=<!--> <!-->1.04; 95%<!--> <!-->CI: 1.01-1,07; <em>P</em> <!-->=<!--> <!-->.033) and pre-donation eGFR (HRa<!--> <!-->=<!--> <!-->0,97; 95%<!--> <!-->CI: 0.95-0,99; <em>P</em> <!-->=<!--> <!-->.028). No patient progressed to CKD<!--> <!-->IV, V or died during follow-up.</div></div><div><h3>Conclusion</h3><div>There were subtle changes in the characteristics of the accepted KR. Age and baseline eGFR were independent predictors of progression to CKD<!--> <!-->III post-donation. The incidence of advanced CKD and mortality were null at 10<!--> <!-->years of post-donation follow-up, so it seems to be a safe procedure in our environment in the long term.</div></div>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"165 4","pages":"Article 107062"},"PeriodicalIF":2.6,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144472193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medicina ClinicaPub Date : 2025-06-23DOI: 10.1016/j.medcli.2025.107065
Ying Zhao , Xiaoying Zhang , Yongsheng Li , Jinhua He , Zeping Han
{"title":"Enterocolic lymphocytic phlebitis: Clinical insights from a literature review","authors":"Ying Zhao , Xiaoying Zhang , Yongsheng Li , Jinhua He , Zeping Han","doi":"10.1016/j.medcli.2025.107065","DOIUrl":"10.1016/j.medcli.2025.107065","url":null,"abstract":"<div><h3>Objective</h3><div>Enterocolic lymphocytic phlebitis (ELP) is a rare venous-specific gastrointestinal inflammation with challenging preoperative diagnosis. We aimed to characterize its clinicopathological spectrum.</div></div><div><h3>Patients and methods</h3><div>This narrative review synthesizes evidence from 85 published cases (9–81 years) from 50 articles to characterize ELP's clinicopathological features and diagnostic pitfalls, along with its differentiation from other vasculitides, such as Behcet's disease, systemic lupus erythematosus, mesenteric inflammatory veno-occlusive disease, idiopathic myointimal hyperplasia of the mesenteric veins and IgG4-related diseases.</div></div><div><h3>Results</h3><div>ELP has a wide range of clinical and histological presentations, it predominantly affects the right colon/small bowel, mimicking acute abdomen. Diagnosis relies on postoperative histopathology showing venular lymphocytic infiltration.</div></div><div><h3>Conclusion</h3><div>ELP represents a underdiagnosed clinicopatologic entity, a diagnosis of ELP is predominantly made after histological resection.</div></div>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"165 5","pages":"Article 107065"},"PeriodicalIF":2.6,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144364765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}